Correcting for heterogeneity and non‐comparability bias in multicenter clinical trials with a rescaled random‐effect excess hazard model
From MaRDI portal
Recommendations
- A comparison of risk difference estimators in multi-center studies under baseline-risk heterogeneity
- Estimating Risk Difference in Multicenter Studies Under Baseline‐Risk Heterogeneity
- Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials
- A Multiresolution Hazard Model for Multicenter Survival Studies
- Deriving Approximations in a Random Effects Model for Multicenter Clinical Trials with Binary Response
- Estimating Cumulative Treatment Effects in the Presence of Nonproportional Hazards
- Quantifying treatment differences in confirmatory trials under non-proportional hazards
- Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel-group RCT: a structural model approach
Cites work
- A log-rank-type test to compare net survival distributions
- A new look at the statistical model identification
- A Tutorial on Multilevel Survival Analysis: Methods, Models and Applications
- Asymptotic Properties of Maximum Likelihood Estimators and Likelihood Ratio Tests Under Nonstandard Conditions
- Diagnosing misspecification of the random‐effects distribution in mixed models
- Nondissipative and energy-stable high-order finite-difference interface schemes for 2-D patch-refined grids
- One-sided tests in shared frailty models
- Score test of homogeneity for survival data. (With discussion)
- Survival and event history analysis. A process point of view
- The frailty model.
Cited in
(2)
This page was built for publication: Correcting for heterogeneity and non‐comparability bias in multicenter clinical trials with a rescaled random‐effect excess hazard model
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6183916)
